Ara MN., Hyodo M., Ohga N., Hida K., Harashima H.: Development of a novel DNA aptamer ligand against primary cultured tumor endothelial cells, PLoS ONE, 7(12), e50174, 2012.
Takara K., Hiroto Hatakeyama H., Kibria G., Ohga N., Hida K., Harashima H.:Size-controlled, dual-ligand modified liposomes that target the tumor vasculature show promise foruse in drug-resistant cancer therapy, J Controlled Release, 162(1), 225-232, 2012
Osawa T., Ohga N. , Hida Y., Kitayama K., Akiyama K., Onodera Y., Fujie M., Shinohara N., Nonomura K., Shindoh M. , *Hida K.: Prostacyclin receptor in tumor endothelial cells promotes angiogenesis in an autocrine manner, Cancer Sci, 103(6), 1038-1044, 2012
Kawamoto T., Ohga N. , Akiyama K., Hirata N., Kitahara S, Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y., *Hida K.: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, PLoS ONE 7(3) :e34045, 2012
Yamamoto K. , Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Matsuda K., Onodera Y., Fujie M., Kaga K., Hirano S, Shinohara N., Shindoh M., *Hida K.: Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells,Br J Cancer, 106(6), 1214-1223, 2012
Maishi N., Ohga N., Hida Y., Akiyama K., Kitayama K., Osawa T., Onodera Y., Nonomura K., Shinohara N., Shindoh M., *Hida K. : CXCR7 : A novel tumor endothelial marker in renal cell carcinoma, Pathol Int, 62(5), 309-317, 2012
Ohga N., Ishikawa S., Maishi N., Akiyama K., Hida Y., Kawamoto T., Sadamoto Y., Osawa T.,Yamamoto K., Kondoh M., Ohmura H., Shinohara N., Nonomura K., Shindoh M., *Hida K.:Heterogeneity of Tumor Endothelial Cells: Comparison between Tumor Endothelial Cells Isolated from Highly Metastatic and Low Metastatic Tumors, Am J Pathol, 180(3), 1294-1307, 2012
Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Ishikawa S., Maishi N., Akino T., Kondoh M., Matsuda A., Inoue N., Shindoh M. and *Hida K.: Tumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment, Am J Pathol, 180(3), 1283-1293, 2012
招待講演
Hida K.:“Heterogeneity of Tumor Endothelial Cells.”The 43rd International Symposium of The Princess Takamatsu Cancer Research Fund“Cancer Heterogeneity: Impact on Carcinogenesis, Cancer Stem Cell, Microenvironment, Diagnosis and Treatment” 2012.11.15(Tokyo, Japan)
Hida K.:“Altered phenotype in endothelial cells in tumor microenvironment.”The 2nd International Symposium by JSPS Core-to-Core Program“Cooperative International Framework in TGF-β Family Signaling” 2012.10.30(Tokyo, Japan)
Hida K.:“Crosstalk between tumor endothelial cells and tumor cells.”The 71st Annual Meeting of the Japanese Cancer Association, 2012.9.21(Sapporo, Japan)
Hida K.:Finding Specific Anti-cancer Drugs Using Human Tumor Vascular Cells. 7th Annual International Partnering Conference “BIO-Europe Spring 201”, 2012.3.11-13, Barcelona, Spain
Hida K., Omura H., Akiyama K., Ohga N., Maishi N., Kawamoto T., Kondoh M., Hida Y.: Characterization of stem-like tumor endothelial cells, The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
Ohga N., Yamamoto K., Hida Y., Maishi N., Kawamoto T., Shindoh M., Hida K. : Biglycan is an autocrine angiogenic factor of tumor endothelial cells,The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
Akiyama K., Ohga N., Hida Y., Maishi N., Alam Mohammad Towfik., Kawamoto T., Omura H., Yamada K., Torii C., Sakamoto H. Matsuda A., Hida K.:Tumor endothelium acquires drugresistance by MDR1/P-gp upregulationand metronomic chemotherapycombined with P-gp inhibitor enhancesantiangiogenic activity in vivo,The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
Kondoh M., Ohga N., Akiyama K., Maishi N., Kawamoto T., Hida Y., Shindoh M., Hida K.: Hypoxia induces angiogenic factors andaneuploidy in micirovascular endothelialcells,The 20th annual Meeting of the Japanese Vascular Biology and MedicineOrganization, The 10th Korea-Japan Joint Symposium on Vascular Biology, 2012.12. 5-7, Tokushima, Japan
Hida K.:“Heterogeneity of Tumor Endothelial Cells.” The 43rd International Symposium of The Princess Takamatsu Cancer Research Fund“Cancer Heterogeneity: Impact on Carcinogenesis, Cancer Stem Cell, Microenvironment, Diagnosis and Treatment” 2012.11.15(Tokyo, Japan)
Hida K.:“Altered phenotype in endothelial cells in tumor microenvironment.”The 2nd International Symposium by JSPS Core-to-Core Program“Cooperative International Framework in TGF-β Family Signaling” 2012.10.30(Tokyo, Japan)
Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Kaga K., Shinohara N., Shindoh M., Hirano S., Hida K. :Biglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells, the 17th International Vascular Biology Meeting, 2012.6.5, Wiesbaden, Germany
Hida K., Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Maishi N., Akino T., Kondoh M., Shindoh M.: Tumor endothelial cell s acquire drug resistance by MDR1 upregulation, the 17th International Vascular Biology Meeting, 2012.6.4, Wiesbaden, Germany
Kawamoto T., Ohga N., Akiyama K., Hirata N., Kitahara S., Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y.,Hida K.: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis,the 17th International Vascular Biology Meeting, 2012.6.4, Wiesbaden, Germany
Maishi N., Ohba Y., Yamamoto K., Ohga N., Hamada J., Akiyama K., Kawamoto T., Osawa T., Kondoh M., Ohmura H., Shindoh M., Hida Y., Hida K. : Contribution of tumor endothelial cells to tumor metastasis, the 17th International Vascular Biology Meeting, 2012.6.2, Wiesbaden, Germany
Yamamoto K., Ohga N., Hida Y., Maishi N., Kawamoto T., Kitayama K., Akiyama K., Osawa T., Kondoh M., Kaga K., Hirano S., Shinohara N., Shindoh M., Hida K. : Biglycan is a specific marker and an autocrine angiogenic factor of tumor endothelial cells, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois
Osawa T., Ohga N., Hida Y., Kitayama K., Yamamoto Y., Kawamoto T., Maishi N., Kondoh M., Akiyama K., Onodera Y., Shinohara N., Nonomura K., Shindoh M., Hida K. : The role of lysyl oxidase on proangiogenic phenotypes of tumor endothelial cells, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois
Akiyama K., Ohga N., Hida Y., Kawamoto T., Sadamoto Y., Ishikawa S., Maishi N., Tomoshige A., Kondoh M., Matsuda A., Inoue N., Shindoh M., Hida K. : Tumor endothelial cells acquire drug resistance by MDR1 upregulation via VEGF signaling in tumor microenvironment, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois
Kawamoto T., Ohga N., Akiyama K., Hirata N., Maishi N., Osawa T., Yamamoto K., Kondoh M., Shindoh M., Hida Y., Hida K.:Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, AACR ANNUAL MEETING 2012, 2012.4.2, Chicago, Illinois
国内学会発表
樋田京子:Crosstalk between tumor endothelial cells and tumor cells, 第71回日本癌学会学術総会, 2012.9.21(札幌)
川本泰輔,大賀則孝, 秋山廣輔,平田尚也,北原秀治,間石奈湖,大澤崇宏,山本和幸,近藤美弥子,進藤正信,樋田泰浩,樋田京子: Tumor-derived microvesicles induce proangiogenic phenotype in endothelial cells via endocytosis, 第71回日本癌学会学術総会, 2012.9.21(札幌)
大賀則孝,山本和幸,樋田泰浩,秋山廣輔,間石奈湖,川本泰輔,北山和子,大澤崇宏, 平野 聡, 篠原信雄,進藤正信, *樋田京子,: Biglycan is a specific marker and an autocrine angiogenic factor of tumour endothelial cells, 第71回日本癌学会学術総会, 2012.9.21(札幌)
秋山廣輔,大澤崇宏,大賀則孝,樋田泰浩,北山和子,川本泰輔,山本和幸,間石奈湖,近藤美弥子,篠原信雄,野々村克也,進藤正信,樋田京子 : The role of Lysyl oxidase on proangiogenic phenotypes of tumor endothelial cells, 第71回日本癌学会学術総会, 2012.9.21(札幌)
間石奈湖,大場雄介,大賀則孝,秋山廣輔,山本和幸,浜田淳一,川本泰輔,大澤崇宏,近藤美弥子,大村 瞳,進藤正信,樋田泰浩,樋田京子: The role of tumor endothelial cells in tumor metastasis, 第71回日本癌学会学術総会, 2012.9.21(札幌)